2-Aminopyridine
|
CAS
504-29-0
|
NH2C5H4N
|
RTECS
US1575000
|
Synonyms & Trade Names
alpha-Aminopyridine, alpha-Pyridylamine
|
DOT ID & Guide
2671 / 153
|
Exposure
Limits
|
NIOSH REL: TWA 0.5 ppm (2 mg/m3)
|
|
OSHA PEL: TWA 0.5 ppm (2 mg/m3)
|
IDLH
5 ppm
See: 504290
|
Conversion
1 ppm = 3.85 mg/m3
|
Physical Description
White powder, leaflets, or crystals with a characteristic odor.
|
MW: 94.1
|
BP: 411°F
|
MLT: 137°F
|
Sol: >100%
|
VP(77°F): 0.8 mmHg
|
IP: 8.00 eV
|
|
Sp.Gr: ?
|
Fl.P: 154°F
|
UEL: ?
|
LEL: ?
|
|
|
Combustible Solid
|
Incompatibilities & Reactivities
Strong oxidizers
|
Measurement Methods
NIOSH S158 (II-4)
See: NMAM or OSHA Methods |
Personal Protection & Sanitation (See protection)
Skin: Prevent skin contact
Eyes: Prevent eye contact
Wash skin: When contaminated
Remove: When wet or contaminated
Change: Daily
Provide: Quick drench
|
First Aid (See procedures)
Eye: Irrigate immediately
Skin: Water flush immediately
Breathing: Respiratory support
Swallow: Medical attention immediately
|
Respirator Recommendations
NIOSH/OSHA
Up to 5 ppm:
(APF = 10) Any supplied-air respirator*
(APF = 50) Any self-contained breathing apparatus with a full facepiece
Emergency or planned entry into unknown concentrations or IDLH conditions:
(APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode
(APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus
Escape:
(APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister having an N100, R100, or P100 filter. Click here for information on selection of N, R, or P filters./Any appropriate escape-type, self-contained breathing apparatus
Important additional information about respirator selection
|
Exposure Routes
inhalation, skin absorption, ingestion, skin and/or eye contact
|
Symptoms
Irritation eyes, nose, throat; headache, dizziness; excitement; nausea; high blood pressure; respiratory distress; lassitude (weakness, exhaustion); convulsions; stupor
|
Target Organs
central nervous system, respiratory system
|
|
See also: INTRODUCTION
See ICSC CARD: 0214 |
